副腎皮質腺腫
- 関
- adrenal cortical adenoma
WordNet
- of or derived from the cortex of the adrenal glands
- a benign epithelial tumor of glandular origin
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/07/03 21:59:17」(JST)
[Wiki en表示]
Adrenocortical adenoma |
Classification and external resources |
|
ICD-O: |
8370/0 |
eMedicine |
radio/13 |
MeSH |
D018246 |
A adrenocortical adenoma (or adrenal cortical adenoma) is a benign tumor of the adrenal cortex.
It can present with Cushing's syndrome or primary aldosteronism.[1]
Is a well circumscribed, yellow tumour in the adrenal cortex, which is usually 2-5 cm in diameter. The color of the tumour, as with adrenal cortex as a whole, is due to the stored lipid (mainly cholesterol), from which the cortical hormones are synthesized. These tumors are frequent incidental findings at post mortem examination, and appear to have produced no significant metabolic disorder; only a very small percentage lead to Cushing's syndrome. Nevertheless, these apparently non-functioning adenomas are most often encountered in elder obese people. There is some debate that they may really represent nodules in diffuse nodular cortical hyperplasia. Very occasionally, a true adrenal cortical adenoma is associated with the clinical manifestations of Conn's syndrome, and can be shown to be excreting mineralocorticoids.
Additional images[edit]
See also[edit]
References[edit]
- ^ "Definition: adrenocortical adenoma from Online Medical Dictionary".
Glandular and epithelial neoplasms (ICD-O 8010-8589)
|
|
Epithelium |
Papilloma/carcinoma
(8010-8139) |
- Small cell carcinoma
- Combined small cell carcinoma
- Verrucous carcinoma
- Squamous cell carcinoma
- Basal cell carcinoma
- Transitional cell carcinoma
- Inverted papilloma
|
|
|
Glands |
Adenomas/
adenocarcinomas
(8140-8429) |
Gastrointestinal |
- tract: Linitis plastica
- Familial adenomatous polyposis
- pancreas
- Insulinoma
- Glucagonoma
- Gastrinoma
- VIPoma
- Somatostatinoma
- Cholangiocarcinoma
- Klatskin tumor
- Hepatocellular adenoma/Hepatocellular carcinoma
|
|
Urogenital |
- Renal cell carcinoma
- Endometrioid tumor
- Renal oncocytoma
|
|
Endocrine |
- Prolactinoma
- Multiple endocrine neoplasia
- Adrenocortical adenoma/Adrenocortical carcinoma
- Hurthle cell
|
|
Other/multiple |
- Neuroendocrine tumor
- Adenoid cystic carcinoma
- Oncocytoma
- Clear cell adenocarcinoma
- Apudoma
- Cylindroma
- Papillary hidradenoma
|
|
|
Adnexal and
skin appendage (8390-8429) |
- sweat gland
- Syringocystadenoma papilliferum
|
|
Cystic, mucinous,
and serous (8440-8499) |
Cystic general |
- Cystadenoma/Cystadenocarcinoma
|
|
Mucinous |
- Signet ring cell carcinoma
- Mucinous cystadenoma / Mucinous cystadenocarcinoma
- Mucoepidermoid carcinoma
|
|
Serous |
- Ovarian serous cystadenoma / Pancreatic serous cystadenoma / Serous cystadenocarcinoma / Papillary serous cystadenocarcinoma
|
|
|
Ductal, lobular,
and medullary (8500-8549) |
Ductal carcinoma |
- Mammary ductal carcinoma
- Pancreatic ductal carcinoma
- Comedocarcinoma
- Paget's disease of the breast / Extramammary Paget's disease
|
|
Lobular carcinoma |
- Lobular carcinoma in situ
- Invasive lobular carcinoma
|
|
Medullary carcinoma |
- Medullary carcinoma of the breast
- Medullary thyroid cancer
|
|
|
Acinar cell (8550-8559) |
|
|
|
Other |
Complex epithelial (8560-8589) |
|
|
|
- See also
- Template:Epithelium and epithelial tissue
|
|
Tumors: endocrine gland neoplasia (C73–C75/D34–D35, 193–194/226–227)
|
|
Pancreas/
islets of Langerhans |
- neuroendocrine tumors/islet cell carcinoma: α: Glucagonoma
- β: Insulinoma
- δ: Somatostatinoma
- G: Gastrinoma
- VIPoma
|
|
Hypothalamic/
pituitary axes
+parathyroid |
Pituitary |
- Pituitary adenoma: Prolactinoma
- ACTH-secreting pituitary adenoma
- GH-secreting pituitary adenoma
|
|
Thyroid |
- Thyroid cancer (malignant): epithelial cell carcinoma
- Papillary
- Follicular/Hurthle cell
- parafollicular cell
- Anaplastic
- Lymphoma
- Squamous cell carcinoma
- Benign: Thyroid adenoma
- Struma ovarii
|
|
Parathyroid |
- Parathyroid adenoma
- Parathyroid carcinoma
|
|
Adrenal tumor |
- adrenal cortex
- Adrenocortical adenoma
- Adrenocortical carcinoma
- adrenal medulla
- Pheochromocytoma
- Neuroblastoma
- see also: Paraganglioma
|
|
Gonads |
|
|
|
Pinealoma |
- Pinealoblastoma
- Pineocytoma
|
|
MEN |
|
|
|
|
noco (d)/cong/tumr, sysi/epon
|
proc, drug (A10/H1/H2/H3/H5)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Glutamate receptors and the regulation of steroidogenesis in the human adrenal gland: the metabotropic pathway.
- Felizola SJ, Nakamura Y, Satoh F, Morimoto R, Kikuchi K, Nakamura T, Hozawa A, Wang L, Onodera Y, Ise K, McNamara KM, Midorikawa S, Suzuki S, Sasano H.Author information Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Japan.AbstractBACKGROUND: l-glutamate is a major excitatory neurotransmitter in the mammalian brain. Glutamate receptors have been reported in the rat adrenal cortex and in human aldosterone-producing adenomas (APA). However, details regarding the expression levels and functions of these receptors in human adrenocortical tissues remain unknown.
- Molecular and cellular endocrinology.Mol Cell Endocrinol.2014 Jan 25;382(1):170-7. doi: 10.1016/j.mce.2013.09.025. Epub 2013 Sep 27.
- BACKGROUND: l-glutamate is a major excitatory neurotransmitter in the mammalian brain. Glutamate receptors have been reported in the rat adrenal cortex and in human aldosterone-producing adenomas (APA). However, details regarding the expression levels and functions of these receptors in human adreno
- PMID 24080311
- Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study.
- Morelli V, Reimondo G, Giordano R, Della Casa S, Policola C, Palmieri S, Salcuni AS, Dolci A, Mendola M, Arosio M, Ambrosi B, Scillitani A, Ghigo E, Beck-Peccoz P, Terzolo M, Chiodini I.Author information Department of Clinical Sciences and Community Health, University of Milan, Milan.AbstractContext. The long-term consequences of subclinical hypercortisolism (SH) in patients with adrenal incidentalomas (AI) are unknown. Setting-Patients. In this retrospective multicentric study, 206 AI patients with a ≥5 yrs follow-up (median, range: 72.3, 60-186 months) were enrolled. Intervention-Main Outcome Measure. The adrenocortical function, adenoma size, metabolic changes and incident cardiovascular events (CVE) were assessed. We diagnosed SH in 11.6% of patients, in the presence of cortisol after 1mg-dexamethasone suppression test (1mg-DST) >5 μg/dL (138 nmol/L) or ≥2 out of: low ACTH, increased urinary free cortisol and 1mg-DST >3 μg/dL (83 nmol/L). Results. At baseline, age, CVE and type-2 diabetes (T2DM) prevalence were higher in patients with than in patients without SH (62.2±11yrs vs 58.5±10yrs; 20.5% vs 6%; 33.3% vs 16.8%, respectively, P<0.05). SH and T2DM were associated with prevalent CVE (OR 3.1, 95%CI 1.1-9.0 and OR 2.0, 95%CI 1.2-3.3, respectively) regardless of age. At the end of the follow-up, SH was diagnosed in 15 patients without SH at baseline. An adenoma size >2.4 cm was associated with the risk of developing SH (SN 73.3%, SP 60.5%, P=0.014). Weight, glycemic, lipidic and blood pressure control worsened in 26%, 25%, 13% and 34% of patients, respectively. A new CVE occurred in 22 patients. SH was associated with the worsening of ≥2 metabolic parameters (OR 3.32, 95%CI 1.6-6.9) and with incident CVE (OR 2.7, 95%CI 1.0-7.1) regardless of age and follow-up. Conclusion. SH is associated with the risk of incident CVE. Beside the clinical follow-up, in patients with an AI >2.4 cm also a long-term biochemical follow-up is required, for the risk of SH development.
- The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2014 Jan 1:jc20133527. [Epub ahead of print]
- Context. The long-term consequences of subclinical hypercortisolism (SH) in patients with adrenal incidentalomas (AI) are unknown. Setting-Patients. In this retrospective multicentric study, 206 AI patients with a ≥5 yrs follow-up (median, range: 72.3, 60-186 months) were enrolled. Intervention-Ma
- PMID 24423350
- LowER EXPRESSION OF THE TWIK-RELATED ACID-SENSITIVE K+ CHANNEL 2 (TASK-2) GENE IS A HALLMARK OF ALDOSTERONE PRODUCING ADENOMA CAUSING HUMAN PRIMARY ALDOSTERONISM.
- Lenzini L, Caroccia B, Campos AG, Fassina A, Belloni AS, Seccia TM, Kuppusamy M, Ferraro S, Skander G, Bader M, Rainey WE, Rossi GP.Author information Internal Medicine 4 &AbstractContext. The molecular mechanisms of primary aldosteronism, a common cause of human hypertension, are unknown, but alterations of K+ channels can play a key role. Objective. To investigate: i) the expression of the Twik-related Acid-Sensitive K+ channels (TASK) in Aldosterone Producing Adenomas (APAs); ii) the role of TASK-2 in aldosterone synthesis; iii) the determinants of TASK-2 blunted expression in APA. Design. We analyzed the transcriptome and the microRNA profiles of 32 consecutive APA and investigated the protein expression and localization of TASK-2 in APA and adrenocortical cell lines (H295R and HAC15) using immunoblotting and confocal microscopy. The functional effect of TASK-2 blunted activity caused by a dominant negative mutation on steroidogenic enzymes and aldosterone production was also assessed. TASK-2 regulation by selected microRNA was studied by a luciferase assay. Results. TASK-2 was consistently less expressed at the transcript and protein level in APAs than in the normal human adrenal cortex. H295R cells transfection with a TASK-2 dominant negative mutant construct significantly increased the aldosterone production by 153% and the gene expression of Aldosterone synthase (CYP11B2, gene expression fold change 3.1 vs control, p<0.05) and of the Steroidogenic acute regulatory protein (STAR) (gene expression fold change 1.8 vs control, p <0.05). Two microRNAs - hsa-miR-23 and hsa-miR-34- were found to decrease TASK-2 expression by binding to the 3' UTR of the TASK-2 gene. Conclusions. The TASK-2 channel lower expression represents a hallmark of APA and is associated to a higher expression of hsa-miR-23 and hsa-miR-34. The ensuing blunted TASK-2 activity increased the production of aldosterone in vitro and the expression of STAR and CYP11B2. Hence, the lower expression of TASK-2 channel in APA cells can explain high aldosterone secretion in human primary aldosteronism in spite of the suppression of angiotensin II, the hypertension and the hypokalemia.
- The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2013 Dec 20:jc20132900. [Epub ahead of print]
- Context. The molecular mechanisms of primary aldosteronism, a common cause of human hypertension, are unknown, but alterations of K+ channels can play a key role. Objective. To investigate: i) the expression of the Twik-related Acid-Sensitive K+ channels (TASK) in Aldosterone Producing Adenomas (APA
- PMID 24285684
Japanese Journal
- 原発性アルドステロン症に併発したサブクリニカルクッシング症候群が症候性に移行した1例
- 稲垣 裕介,植村 元秀,中田 渡 [他],中井 康友,高山 仁志,辻村 晃,野々村 祝夫,北村 哲宏,大月 道夫
- 泌尿器科紀要 = Acta urologica Japonica 59(11), 719-722, 2013-11
- … The histopathological examination revealed an adrenocortical adenoma. …
- NAID 120005350254
- 4. 副腎の外科(<特集>内分泌外科の現状と将来)
- An unusual presentation of Carney complex with diffuse primary pigmented nodular adrenocortical disease on one adrenal gland and a nonpigmented adrenocortical adenoma and focal primary pigmented nodular adrenocortical disease on the other
- TUNG Shih-Chen,HWANG Daw-Yang,YANG Joseph W.,CHEN Wei-Jen,LEE Chien-Te
- Endocrine journal 59(9), 823-830, 2012-09-01
- NAID 10031123126
Related Links
- 28 year old woman with testosterone-producing adrenocortical adenoma also showing signs of subclinical Cushing's syndrome (Endocr J 1995;42:283) 39 year old man with cosecretion of estrogen and inhibin B by a feminizing ...
- Top of page MATERIALS AND METHODS Patient Search and Inclusion and Exclusion Criteria We identified 67 consecutively treated patients with histologically confirmed adrenocortical carcinoma from the Memorial ...
Related Pictures
★リンクテーブル★
[★]
- 英
- adrenocortical adenoma、adrenal cortical adenoma
- 関
- 副腎皮質。副腎腫瘍
[★]
副腎皮質腺腫
- 関
- adrenocortical adenoma
[★]
- 関
- adrenal cortex、adrenal cortical、adrenal cortices
[★]
- 関
- gland、glandular